Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

[1]  F. Sigaux,et al.  Inactivation of the ATM gene in T-cell prolymphocytic leukemias. , 1998, Blood.

[2]  M. James,et al.  Biallelic mutations in the ATM gene in T-prolymphocytic leukemia , 1997, Nature Medicine.

[3]  M. Dyer,et al.  Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia , 1997, Nature Genetics.

[4]  J. Hopper,et al.  AT-tributable risks? , 1997, Nature Genetics.

[5]  K. Isselbacher,et al.  Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.

[6]  M. Swift,et al.  Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.

[7]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[8]  J. Boice,et al.  Risk of breast cancer in ataxia-telangiectasia. , 1992, The New England journal of medicine.

[9]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[10]  P. Møller,et al.  Breast cancer and other cancers in Norwegian families with ataxia‐telangiectasia , 1990, Genes, chromosomes & cancer.

[11]  A. Hall,et al.  Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. , 1988, Cancer research.

[12]  M. Swift,et al.  Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.

[13]  D. Easton.  Cancer risks in A-T heterozygotes. , 1994, International journal of radiation biology.

[14]  L. Wagner.  Risk of breast cancer in ataxia-telangiectasia. , 1992, The New England journal of medicine.

[15]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.